Jun Hui Liu
President chez Yunnan Oriental Anti-Aging Biotechnology Co. Ltd.
Fortune : 115 M $ au 31/03/2024
Profil
Jun Hui Liu is currently the President & Director at Yunnan Oriental Anti-Aging Biotechnology Co. Ltd.
He previously worked as a Director at Walvax Biotechnology Co., Ltd.
and as a Member-Supervisory Board at Beijing ChinaEquity Investment Co., Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 54 161 648 ( 3,48% ) | 115 M $ | 31/03/2024 |
Postes actifs de Jun Hui Liu
| Sociétés | Poste | Début |
|---|---|---|
| Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. | President | 05/01/2012 |
Anciens postes connus de Jun Hui Liu
| Sociétés | Poste | Fin |
|---|---|---|
Beijing ChinaEquity Investment Co., Ltd.
 Beijing ChinaEquity Investment Co., Ltd. Investment ManagersFinance Beijing ChinaEquity Investment Co. Ltd. operates as a private equity and venture capital firm, which engages in early, later stage, high growth, mergers and acquisitions investments. It invests in wide range of industries, including TMT, high-end consumer & retail, clean energy and healthcare. The company was founded by Chao Yong Wang on May 17,1999 and is headquartered in Beijing, China. | Director/Board Member | - |
| WALVAX BIOTECHNOLOGY CO., LTD. | Director/Board Member | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
 | Finance |
| Entreprise privées | 1 |
|---|---|
| Yunnan Oriental Anti-Aging Biotechnology Co. Ltd. |
